Therapeutic Focus

Q Therapeutics is addressing the critical unmet need for treatments that target the underlying causes and mechanisms of currently incurable CNS diseases

Every year, hundreds of thousands of people suffer from debilitating – and often fatal – diseases of the brain and spinal cord. Currently, the available treatments for most devastating neurodegenerative disorders target only symptoms, not the underlying causes of central nervous system (CNS) disease or injury.

By augmenting the population of healthy glia in the brain and spinal cord, Q-Cells® have the potential to modify the course of neurodegenerative and demyelinating diseases and injuries by rescuing damaged neurons or replacing diseased glial cells.
Current Targets
  • Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig’s Disease)
  • Transverse Myelitis
  • Multiple Sclerosis
  • Spinal Cord Injury
Future Targets
  • Huntington’s Disease
  • Parkinson’s Disease
  • Alzheimer’s Disease
  • Stroke
  • Traumatic Brain Injury